AI has massive potential across the entire pharmaceutical value chain and the broader healthcare industry. This report will drill down into some of the most exciting opportunities within the pharmaceutical value chain, including drug discovery and development, clinical trials, manufacturing, and supply chain management—key segments where AI is driving significant advancements.
Gain the insights and strategies needed to navigate the complexities of scaling AI integration, from ethical considerations and AI literacy to regulatory constraints
From target identification to precision screening, AI has proven its value. The next step is scaling these breakthroughs to reduce timelines and boost success rates across the drug development pipeline
Clinical Trials 2.0
AI is streamlining patient recruitment, trial management, and real-world evidence collection. The conference will explore how to make AI-powered trials the norm, optimizing efficiency and compliance
Commercial Strategies
AI-driven tools are revolutionising patient engagement and marketing. Scaling these solutions enables pharma companies to deliver targeted therapies and create long-term value at an unprecedented scale
Very valuable to get an insight what other companies are planning, what challenges they have and discuss possible solutions
Great value event, enjoyed networking and the latest thinking from like minded professionals
Great experience. Benchmarking and networking opportunities was great! Especially liked the What IF scenarios and discussions around that
Very valuable to get an insight what other companies are planning, what challenges they have and discuss possible solutions
It's beneficial to hear stories and solution from my counterparts from various companies
Pharma IQ is the platform for the pharmaceutical community to continue their conversations beyond events. In the past decade, the portal has evolved to be a leading hub for analysis, resources and tools for all aspects of the pharmaceutical field. With an active community openly sharing their challenges, industry leaders offering advice and ample opportunity for collaboration.